Andra AP-fonden’s United Therapeutics UTHR Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $34M | Buy |
118,400
+16,300
| +16% | +$4.68M | 0.47% | 61 |
|
2025
Q1 | $31.5M | Buy |
102,100
+35,500
| +53% | +$10.9M | 0.52% | 45 |
|
2024
Q4 | $23.5M | Buy |
66,600
+5,500
| +9% | +$1.94M | 0.38% | 84 |
|
2024
Q3 | $21.9M | Buy |
61,100
+26,000
| +74% | +$9.32M | 0.32% | 100 |
|
2024
Q2 | $11.2M | Buy |
35,100
+1,900
| +6% | +$605K | 0.19% | 175 |
|
2024
Q1 | $7.63M | Sell |
33,200
-2,300
| -6% | -$528K | 0.14% | 227 |
|
2023
Q4 | $7.81M | Buy |
35,500
+1,100
| +3% | +$242K | 0.41% | 108 |
|
2023
Q3 | $7.77M | Sell |
34,400
-900
| -3% | -$203K | 0.46% | 83 |
|
2023
Q2 | $7.79M | Buy |
+35,300
| New | +$7.79M | 0.2% | 204 |
|
2019
Q2 | – | Sell |
-54,100
| Closed | -$6.35M | – | 680 |
|
2019
Q1 | $6.35M | Buy |
+54,100
| New | +$6.35M | 0.18% | 205 |
|
2018
Q3 | $8.79M | Sell |
68,700
-8,000
| -10% | -$1.02M | 0.23% | 119 |
|
2018
Q2 | $8.68M | Buy |
76,700
+5,900
| +8% | +$668K | 0.23% | 92 |
|
2018
Q1 | $7.96M | Buy |
70,800
+58,200
| +462% | +$6.54M | 0.21% | 135 |
|
2017
Q4 | $1.86M | Sell |
12,600
-3,100
| -20% | -$459K | 0.04% | 584 |
|
2017
Q3 | $1.84M | Sell |
15,700
-11,200
| -42% | -$1.31M | 0.04% | 565 |
|
2017
Q2 | $3.49M | Sell |
26,900
-10,000
| -27% | -$1.3M | 0.09% | 373 |
|
2017
Q1 | $5K | Buy |
36,900
+14,200
| +63% | +$1.92K | 0.12% | 239 |
|
2016
Q4 | $3.26M | Sell |
22,700
-2,300
| -9% | -$330K | 0.09% | 368 |
|
2016
Q3 | $2.95M | Sell |
25,000
-6,300
| -20% | -$744K | 0.08% | 395 |
|
2016
Q2 | $3.32M | Buy |
31,300
+9,700
| +45% | +$1.03M | 0.08% | 361 |
|
2016
Q1 | $2.41M | Buy |
21,600
+7,800
| +57% | +$869K | 0.06% | 479 |
|
2015
Q4 | $2.16M | Sell |
13,800
-6,400
| -32% | -$1M | 0.06% | 459 |
|
2015
Q3 | $2.65M | Sell |
20,200
-1,600
| -7% | -$210K | 0.08% | 397 |
|
2015
Q2 | $3.79M | Buy |
+21,800
| New | +$3.79M | 0.11% | 293 |
|